Healthy Volunteers for Part 6 of Covid 19 Clinical Trial
The Pfizer Clinical Research Unit in New Haven is seeking healthy volunteers for Part 6 of a COVID-19 clinical trial to compare the effects of a supratherapeutic dose of the study drug with a placebo and an additional medication. A supratherapeutic dose is higher than would normally be used to treat a medical condition and is being used in this study to assess the effects and dosing of the study drug. COVID-19 is the illness resulting from the novel coronavirus SARS-CoV-2, affecting millions of people worldwide. Despite efforts to vaccinate against the virus, treatments are still needed for those who become ill to aid in their recovery.
If you choose to participate, you will stay at our facility for up to 20 overnights. Starting the morning after admission, you will receive one of the following study interventions:
- a single supratherapeutic dose of the study drug (split into 2 oral doses an hour apart)
- a placebo, which has no active ingredient (also given as split doses an hour apart)
- a single dose of an additional medication and a placebo an hour apart
You will receive one each of the above doses at least 7 days apart, given on an empty stomach and in a randomly chosen order, for a total of 3 dosing periods.
Throughout the study, staff will closely monitor your health status and collect data, such as the levels of the study drug in your blood.
Up to $7,010 upon completion of the study
This study is seeking healthy adult volunteers, meaning that the participants will not have the condition being studied and are in overall good health. In addition to the criteria listed, participants must meet the following requirements:
- Willing to take a study drug
- Willing and able to come to our facility in New Haven, CT*
- Able to comply with all study procedures and appointments
- 18-60 years
*participants may be eligible to receive a bonus for travel, ask our staff for details
There are other requirements for participation in this study. The study staff will explain these to you during the screening process.